<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460313</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Network Analysis of Dysregulated Immune Response to COVID-19 mRNA Vaccination in Hemodialysis Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1146</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101146</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">End-stage renal disease (ESRD) results in immune dysfunction that is characterized by both systemic inflammation and immune incompetence, leading to impaired responses to vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To unravel the complex regulatory immune interplay in ESRD, we performed the network-based transcriptomic profiling of ESRD patients on maintenance hemodialysis (HD) and matched healthy controls (HCs) who received the two-dose regimen of the COVID-19 mRNA vaccine BNT162b2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Co-expression networks based on blood transcription modules (BTMs) of genes differentially expressed between the HD and HC groups revealed co-expression patterns that were highly similar between the two groups but weaker in magnitude in the HD compared to HC subjects. These networks also showed weakened coregulation between BTMs within the dendritic cell (DC) family as well as with other BTM families involved with innate immunity. The gene regulatory networks of the most enriched BTMs, likewise, highlighted weakened targeting by transcription factors of key genes implicated in DC, natural killer (NK) cell, and T cell activation and function. The computational deconvolution of immune cell populations further bolstered these findings with discrepant proportions of conventional DC subtypes, NK T cells, and CD8+ T cells in HD subjects relative to HCs.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Altogether, our results indicate that constitutive inflammation in ESRD compromises the activation of DCs and NK cells, and, ultimately, their mediation of downstream lymphocytes, leading to a delayed but intact immune response to mRNA vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yi-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jessica M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-4492-2221</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2445-2696</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vagts</LastName><ForeName>Christen L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascoli</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edafetanure-Ibeh</LastName><ForeName>Russell</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherian</LastName><ForeName>Ruth A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarup</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warpecha</LastName><ForeName>Samantha R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Sunghyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goel</LastName><ForeName>Rhea</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turturice</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Palo Alto, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schott</LastName><ForeName>Cody</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Montserrat H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finn</LastName><ForeName>Patricia W</ForeName><Initials>PW</Initials><Identifier Source="ORCID">0000-0001-6936-103X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of New Mexico, Albuquerque, NM 87131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>David L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of New Mexico, Albuquerque, NM 87131, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30HD102093</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30HL151182</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32HL144909</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30HL136001</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30HL127267</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL138628</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-A1S1</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1TR002003</GrantID><Agency>University of Illinois at Chicago Center for Clinical and Translational Science (CCTS)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">end-stage renal disease</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">gene regulatory network</Keyword><Keyword MajorTopicYN="N">hemodialysis</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460313</ArticleId><ArticleId IdType="pmc">PMC11511558</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101146</ArticleId><ArticleId IdType="pii">vaccines12101146</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kato S., Chmielewski M., Honda H., Pecoits-Filho R., Matsuo S., Yuzawa Y., Tranaeus A., Stenvinkel P., Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 2008;3:1526–1533. doi: 10.2215/CJN.00950208.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00950208</ArticleId><ArticleId IdType="pmc">PMC4571158</ArticleId><ArticleId IdType="pubmed">18701615</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M., Heimburger O., Cederholm T., Girndt M. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly. Kidney Int. 2005;67:1216–1233. doi: 10.1111/j.1523-1755.2005.00200.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00200.x</ArticleId><ArticleId IdType="pubmed">15780075</ArticleId></ArticleIdList></Reference><Reference><Citation>Betjes M.G. Immune cell dysfunction and inflammation in end-stage renal disease. Nat. Rev. Nephrol. 2013;9:255–265. doi: 10.1038/nrneph.2013.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.44</ArticleId><ArticleId IdType="pubmed">23507826</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriadis T., Antoniadi G., Liakopoulos V., Kartsios C., Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin. Dial. 2007;20:440–451. doi: 10.1111/j.1525-139X.2007.00283.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2007.00283.x</ArticleId><ArticleId IdType="pubmed">17897251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadiani M.H., Besharati S., Mousavinasab N., Jalalzadeh M. Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients. J. Res. Med. Sci. 2012;17:527–533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634289</ArticleId><ArticleId IdType="pubmed">23626628</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupper A., Sharon N., Finn T., Cohen R., Israel M., Agbaria A., Rechavi Y., Schwartz I.F., Schwartz D., Lellouch Y., et al. Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis. Clin. J. Am. Soc. Nephrol. 2021;16:1037–1042. doi: 10.2215/CJN.03500321.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.03500321</ArticleId><ArticleId IdType="pmc">PMC8425628</ArticleId><ArticleId IdType="pubmed">33824157</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn M., Korth J., Dorsch O., Anastasiou O.E., Sorge-Hadicke B., Tyczynski B., Gackler A., Witzke O., Dittmer U., Dolff S., et al. Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis. Vaccines. 2021;9:360. doi: 10.3390/vaccines9040360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9040360</ArticleId><ArticleId IdType="pmc">PMC8070660</ArticleId><ArticleId IdType="pubmed">33918085</ArticleId></ArticleIdList></Reference><Reference><Citation>Attias P., Sakhi H., Rieu P., Soorkia A., Assayag D., Bouhroum S., Nizard P., El Karoui K. Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients. Kidney Int. 2021;99:1490–1492. doi: 10.1016/j.kint.2021.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8055946</ArticleId><ArticleId IdType="pubmed">33887317</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand S., Montez-Rath M.E., Han J., Garcia P., Cadden L., Hunsader P., Kerschmann R., Beyer P., Dittrich M., Block G.A., et al. Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis. medRxiv. 2021:1–22. doi: 10.1681/ASN.2021050611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021050611</ArticleId><ArticleId IdType="pmc">PMC8722791</ArticleId><ArticleId IdType="pubmed">34117129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.S., Huang K., Lee J.M., Vagts C.L., Ascoli C., Amin M.R., Ghassemi M., Lora C.M., Edafetanure-Ibeh R., Huang Y., et al. Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: Cohort study. medRxiv. 2023:1–39. doi: 10.1101/2023.01.19.23284792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.19.23284792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagigi A., Lore K. Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans. Vaccines. 2021;9:61. doi: 10.3390/vaccines9010061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9010061</ArticleId><ArticleId IdType="pmc">PMC7831080</ArticleId><ArticleId IdType="pubmed">33477534</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Praet J., Reynders M., De Bacquer D., Viaene L., Schoutteten M.K., Caluwe R., Doubel P., Heylen L., De Bel A.V., Van Vlem B., et al. Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study. J. Am. Soc. Nephrol. 2021;32:3208–3220. doi: 10.1681/ASN.2021070908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021070908</ArticleId><ArticleId IdType="pmc">PMC8638385</ArticleId><ArticleId IdType="pubmed">34588184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gollapudi P., Yoon J.W., Gollapudi S., Pahl M.V., Vaziri N.D. Leukocyte toll-like receptor expression in end-stage kidney disease. Am. J. Nephrol. 2010;31:247–254. doi: 10.1159/000276764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000276764</ArticleId><ArticleId IdType="pubmed">20090311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando M., Lundkvist I., Bergstrom J., Lindholm B. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int. 1996;49:773–780. doi: 10.1038/ki.1996.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1996.107</ArticleId><ArticleId IdType="pubmed">8648919</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Fresnedo G., Ramos M.A., Gonzalez-Pardo M.C., de Francisco A.L., Lopez-Hoyos M., Arias M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol. Dial. Transplant. 2000;15:502–510. doi: 10.1093/ndt/15.4.502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/15.4.502</ArticleId><ArticleId IdType="pubmed">10727545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahl M.V., Gollapudi S., Sepassi L., Gollapudi P., Elahimehr R., Vaziri N.D. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol. Dial. Transplant. 2010;25:205–212. doi: 10.1093/ndt/gfp397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfp397</ArticleId><ArticleId IdType="pmc">PMC2796898</ArticleId><ArticleId IdType="pubmed">19684120</ArticleId></ArticleIdList></Reference><Reference><Citation>Macneil L.T., Walhout A.J. Gene regulatory networks and the role of robustness and stochasticity in the control of gene expression. Genome Res. 2011;21:645–657. doi: 10.1101/gr.097378.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.097378.109</ArticleId><ArticleId IdType="pmc">PMC3083081</ArticleId><ArticleId IdType="pubmed">21324878</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.J., Ramsey S.A., Filtz T.M., Kioussi C. Differential gene regulatory networks in development and disease. Cell. Mol. Life Sci. 2018;75:1013–1025. doi: 10.1007/s00018-017-2679-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2679-6</ArticleId><ArticleId IdType="pmc">PMC11105524</ArticleId><ArticleId IdType="pubmed">29018868</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Rouphael N., Duraisingham S., Romero-Steiner S., Presnell S., Davis C., Schmidt D.S., Johnson S.E., Milton A., Rajam G., et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 2014;15:195–204. doi: 10.1038/ni.2789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2789</ArticleId><ArticleId IdType="pmc">PMC3946932</ArticleId><ArticleId IdType="pubmed">24336226</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun R.O., Brunner L., Wyler K., Auray G., Garcia-Nicolas O., Python S., Zumkehr B., Gaschen V., Stoffel M.H., Collin N., et al. System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep. NPJ Vaccines. 2018;3:41. doi: 10.1038/s41541-018-0078-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-018-0078-0</ArticleId><ArticleId IdType="pmc">PMC6170373</ArticleId><ArticleId IdType="pubmed">30302283</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass K., Huttenhower C., Quackenbush J., Yuan G.C. Passing messages between biological networks to refine predicted interactions. PLoS ONE. 2013;8:e64832. doi: 10.1371/journal.pone.0064832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064832</ArticleId><ArticleId IdType="pmc">PMC3669401</ArticleId><ArticleId IdType="pubmed">23741402</ArticleId></ArticleIdList></Reference><Reference><Citation>Blobe G.C., Schiemann W.P., Pepin M.C., Beauchemin M., Moustakas A., Lodish H.F., O’Connor-McCourt M.D. Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J. Biol. Chem. 2001;276:24627–24637. doi: 10.1074/jbc.M100188200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M100188200</ArticleId><ArticleId IdType="pubmed">11323414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Casillas F., Payne H.M., Andres J.L., Massague J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: Mapping of ligand binding and GAG attachment sites. J. Cell Biol. 1994;124:557–568. doi: 10.1083/jcb.124.4.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.124.4.557</ArticleId><ArticleId IdType="pmc">PMC2119924</ArticleId><ArticleId IdType="pubmed">8106553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Francisco S., de la Fuente-Granada M., Alvarez Salazar E.K., Bolanos-Castro L.A., Fonseca-Camarillo G., Olguin-Alor R., Aleman-Muench G.R., Lopez-Casillas F., Raman C., Garcia-Zepeda E.A., et al. TbetaRIII is induced by TCR signaling and downregulated in FoxP3(+) regulatory T cells. Biochem. Biophys. Res. Commun. 2017;494:82–87. doi: 10.1016/j.bbrc.2017.10.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.10.081</ArticleId><ArticleId IdType="pubmed">29050936</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P., Klein F., Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69:905–914. doi: 10.1016/0092-8674(92)90610-O.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90610-O</ArticleId><ArticleId IdType="pubmed">1606614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 1998;18:6538–6547. doi: 10.1128/MCB.18.11.6538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.18.11.6538</ArticleId><ArticleId IdType="pmc">PMC109239</ArticleId><ArticleId IdType="pubmed">9774669</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell T.M., Bryceson Y.T. IL2RB maintains immune harmony. J. Exp. Med. 2019;216:1231–1233. doi: 10.1084/jem.20190546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190546</ArticleId><ArticleId IdType="pmc">PMC6547856</ArticleId><ArticleId IdType="pubmed">31068380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim M.J.W., Rajagopalan S., Altmann D.M., Boyton R.J., Sun P.D., Long E.O. Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C. Proc. Natl. Acad. Sci. USA. 2019;116:12964–12973. doi: 10.1073/pnas.1903781116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1903781116</ArticleId><ArticleId IdType="pmc">PMC6601252</ArticleId><ArticleId IdType="pubmed">31138701</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter C.C., Gumperz J.E., Parham P., Long E.O., Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 1998;161:571–577. doi: 10.4049/jimmunol.161.2.571.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.161.2.571</ArticleId><ArticleId IdType="pubmed">9670929</ArticleId></ArticleIdList></Reference><Reference><Citation>Herring J.A., Elison W.S., Tessem J.S. Function of Nr4a Orphan Nuclear Receptors in Proliferation, Apoptosis and Fuel Utilization Across Tissues. Cells. 2019;8:1373. doi: 10.3390/cells8111373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8111373</ArticleId><ArticleId IdType="pmc">PMC6912296</ArticleId><ArticleId IdType="pubmed">31683815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito S., Tanaka Y., Oshino R., Aiba K., Thanasegaran S., Nishio N., Isobe K. GADD34 inhibits activation-induced apoptosis of macrophages through enhancement of autophagy. Sci. Rep. 2015;5:8327. doi: 10.1038/srep08327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08327</ArticleId><ArticleId IdType="pmc">PMC4321179</ArticleId><ArticleId IdType="pubmed">25659802</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinsimon S., Longmuss E., Rolff J., Jager S., Eggert A., Delebinski C., Seifert G. GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway. Sci. Rep. 2018;8:5750. doi: 10.1038/s41598-018-24075-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24075-x</ArticleId><ArticleId IdType="pmc">PMC5893628</ArticleId><ArticleId IdType="pubmed">29636527</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaspyridonos M., Matei I., Huang Y., do Rosario Andre M., Brazier-Mitouart H., Waite J.C., Chan A.S., Kalter J., Ramos I., Wu Q., et al. Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat. Commun. 2015;6:6840. doi: 10.1038/ncomms7840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7840</ArticleId><ArticleId IdType="pmc">PMC4423225</ArticleId><ArticleId IdType="pubmed">25924227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Liu Y., Han R., Beier U.H., Thomas R.M., Wells A.D., Hancock W.W. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function. Mol. Cell. Biol. 2013;33:4106–4115. doi: 10.1128/MCB.00144-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00144-13</ArticleId><ArticleId IdType="pmc">PMC3811679</ArticleId><ArticleId IdType="pubmed">23979593</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila Cobos F., Alquicira-Hernandez J., Powell J.E., Mestdagh P., De Preter K. Benchmarking of cell type deconvolution pipelines for transcriptomics data. Nat. Commun. 2020;11:5650. doi: 10.1038/s41467-020-19015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19015-1</ArticleId><ArticleId IdType="pmc">PMC7648640</ArticleId><ArticleId IdType="pubmed">33159064</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam P.S., Scott M.K.D., Hagan T., Li C., Feng Y., Wimmers F., Grigoryan L., Trisal M., Edara V.V., Lai L., et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021;596:410–416. doi: 10.1038/s41586-021-03791-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03791-x</ArticleId><ArticleId IdType="pmc">PMC8761119</ArticleId><ArticleId IdType="pubmed">34252919</ArticleId></ArticleIdList></Reference><Reference><Citation>Boltjes A., Samat A.A.K., Plantinga M., Mokry M., Castelijns B., Swart J.F., Vastert S.J., Creyghton M., Nierkens S., van Loosdregt J., et al. Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis. Front. Immunol. 2022;13:1101999. doi: 10.3389/fimmu.2022.1101999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1101999</ArticleId><ArticleId IdType="pmc">PMC9846246</ArticleId><ArticleId IdType="pubmed">36685500</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhang X., Cheng Y., Cao X. Dendritic cell migration in inflammation and immunity. Cell. Mol. Immunol. 2021;18:2461–2471. doi: 10.1038/s41423-021-00726-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00726-4</ArticleId><ArticleId IdType="pmc">PMC8298985</ArticleId><ArticleId IdType="pubmed">34302064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosteels C., Neyt K., Vanheerswynghels M., van Helden M.J., Sichien D., Debeuf N., De Prijck S., Bosteels V., Vandamme N., Martens L., et al. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection. Immunity. 2020;52:1039–1056 e1039. doi: 10.1016/j.immuni.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7207120</ArticleId><ArticleId IdType="pubmed">32392463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.U., Kim M., Kim S., Nguyen T.T., Kim E., Lee S., Kim S., Kim H. Dendritic Cell Dysfunction in Patients with End-stage Renal Disease. Immune Netw. 2017;17:152–162. doi: 10.4110/in.2017.17.3.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2017.17.3.152</ArticleId><ArticleId IdType="pmc">PMC5484645</ArticleId><ArticleId IdType="pubmed">28680376</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkade M.A., van Druningen C.J., Vaessen L.M., Hesselink D.A., Weimar W., Betjes M.G. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol. Dial. Transplant. 2007;22:128–138. doi: 10.1093/ndt/gfl519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl519</ArticleId><ArticleId IdType="pubmed">17005525</ArticleId></ArticleIdList></Reference><Reference><Citation>Satomura A., Endo M., Ohi H., Sudo S., Ohsawa I., Fujita T., Matsushita M., Fujita T. Significant elevations in serum mannose-binding lectin levels in patients with chronic renal failure. Nephron. 2002;92:702–704. doi: 10.1159/000064089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000064089</ArticleId><ArticleId IdType="pubmed">12372959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim W.H., Kireta S., Leedham E., Russ G.R., Coates P.T. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 2007;72:1138–1148. doi: 10.1038/sj.ki.5002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002425</ArticleId><ArticleId IdType="pubmed">17728708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando M., Shibuya A., Tsuchiya K., Akiba T., Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006;70:358–362. doi: 10.1038/sj.ki.5001548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5001548</ArticleId><ArticleId IdType="pubmed">16738534</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E., Trinchieri G., Caux C., Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005;201:1435–1446. doi: 10.1084/jem.20041964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041964</ArticleId><ArticleId IdType="pmc">PMC2213193</ArticleId><ArticleId IdType="pubmed">15851485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M.S., Ghosh S. Regulation of NF-kappaB by TNF family cytokines. Semin. Immunol. 2014;26:253–266. doi: 10.1016/j.smim.2014.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2014.05.004</ArticleId><ArticleId IdType="pmc">PMC4156877</ArticleId><ArticleId IdType="pubmed">24958609</ArticleId></ArticleIdList></Reference><Reference><Citation>Trevejo J.M., Marino M.W., Philpott N., Josien R., Richards E.C., Elkon K.B., Falck-Pedersen E. TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc. Natl. Acad. Sci. USA. 2001;98:12162–12167. doi: 10.1073/pnas.211423598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.211423598</ArticleId><ArticleId IdType="pmc">PMC59785</ArticleId><ArticleId IdType="pubmed">11593031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L.L., Wei X.S., Zhang M., Niu Y.R., Zhou Q. The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells. Front. Immunol. 2018;9:583. doi: 10.3389/fimmu.2018.00583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00583</ArticleId><ArticleId IdType="pmc">PMC5874323</ArticleId><ArticleId IdType="pubmed">29623079</ArticleId></ArticleIdList></Reference><Reference><Citation>Omilusik K.D., Goldrath A.W. The origins of memory T cells. Nature. 2017;552:337–339. doi: 10.1038/d41586-017-08280-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-017-08280-8</ArticleId><ArticleId IdType="pubmed">32080617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisowska K.A., Storoniak H., Debska-Slizien A. T cell subpopulations and cytokine levels in hemodialysis patients. Hum. Immunol. 2022;83:134–143. doi: 10.1016/j.humimm.2021.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2021.11.003</ArticleId><ArticleId IdType="pubmed">34802797</ArticleId></ArticleIdList></Reference><Reference><Citation>Prietl B., Odler B., Kirsch A.H., Artinger K., Eigner M., Schmaldienst S., Pfeifer V., Stanzer S., Eberl A., Raml R., et al. Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19. Front. Immunol. 2022;13:821818. doi: 10.3389/fimmu.2022.821818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.821818</ArticleId><ArticleId IdType="pmc">PMC8901184</ArticleId><ArticleId IdType="pubmed">35265078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tupin E., Kinjo Y., Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007;5:405–417. doi: 10.1038/nrmicro1657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1657</ArticleId><ArticleId IdType="pubmed">17487145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrikx T.K., van Gurp E.A., Mol W.M., Schoordijk W., Sewgobind V.D., Ijzermans J.N., Weimar W., Baan C.C. End-stage renal failure and regulatory activities of CD4+ CD25bright+ FoxP3+ T-cells. Nephrol. Dial. Transplant. 2009;24:1969–1978. doi: 10.1093/ndt/gfp005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfp005</ArticleId><ArticleId IdType="pubmed">19193737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren T., Xiong J., Liu G., Wang S., Tan Z., Fu B., Zhang R., Liao X., Wang Q., Guo Z. Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis. Biosci. Rep. 2019;39:BSR20191585. doi: 10.1042/BSR20191585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20191585</ArticleId><ArticleId IdType="pmc">PMC6822497</ArticleId><ArticleId IdType="pubmed">31427482</ArticleId></ArticleIdList></Reference><Reference><Citation>Cendoroglo M., Jaber B.L., Balakrishnan V.S., Perianayagam M., King A.J., Pereira B.J. Neutrophil apoptosis and dysfunction in uremia. J. Am. Soc. Nephrol. 1999;10:93–100. doi: 10.1681/ASN.V10193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.V10193</ArticleId><ArticleId IdType="pubmed">9890314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.W., Chung B.H., Jeon E.J., Kim B.M., Choi B.S., Park C.W., Kim Y.S., Cho S.G., Cho M.L., Yang C.W. B cell-associated immune profiles in patients with end-stage renal disease (ESRD) Exp. Mol. Med. 2012;44:465–472. doi: 10.3858/emm.2012.44.8.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3858/emm.2012.44.8.053</ArticleId><ArticleId IdType="pmc">PMC3429810</ArticleId><ArticleId IdType="pubmed">22617684</ArticleId></ArticleIdList></Reference><Reference><Citation>Slocombe T., Brown S., Miles K., Gray M., Barr T.A., Gray D. Plasma cell homeostasis: The effects of chronic antigen stimulation and inflammation. J. Immunol. 2013;191:3128–3138. doi: 10.4049/jimmunol.1301163.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301163</ArticleId><ArticleId IdType="pmc">PMC3836257</ArticleId><ArticleId IdType="pubmed">23935195</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins D.J., Patel M.C., Blanco J.C., Vogel S.N. Epigenetic Mechanisms Governing Innate Inflammatory Responses. J. Interferon Cytokine Res. 2016;36:454–461. doi: 10.1089/jir.2016.0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2016.0003</ArticleId><ArticleId IdType="pmc">PMC4931723</ArticleId><ArticleId IdType="pubmed">27379867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargreaves D.C., Horng T., Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell. 2009;138:129–145. doi: 10.1016/j.cell.2009.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.05.047</ArticleId><ArticleId IdType="pmc">PMC2828818</ArticleId><ArticleId IdType="pubmed">19596240</ArticleId></ArticleIdList></Reference><Reference><Citation>Schliehe C., Flynn E.K., Vilagos B., Richson U., Swaminanthan S., Bosnjak B., Bauer L., Kandasamy R.K., Griesshammer I.M., Kosack L., et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat. Immunol. 2015;16:67–74. doi: 10.1038/ni.3046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3046</ArticleId><ArticleId IdType="pmc">PMC4320687</ArticleId><ArticleId IdType="pubmed">25419628</ArticleId></ArticleIdList></Reference><Reference><Citation>Valinluck V., Tsai H.H., Rogstad D.K., Burdzy A., Bird A., Sowers L.C. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2) Nucleic Acids Res. 2004;32:4100–4108. doi: 10.1093/nar/gkh739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh739</ArticleId><ArticleId IdType="pmc">PMC514367</ArticleId><ArticleId IdType="pubmed">15302911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching T., Huang S., Garmire L.X. Power analysis and sample size estimation for RNA-Seq differential expression. RNA. 2014;20:1684–1696. doi: 10.1261/rna.046011.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.046011.114</ArticleId><ArticleId IdType="pmc">PMC4201821</ArticleId><ArticleId IdType="pubmed">25246651</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards N.E., Keshavarz B., Workman L.J., Nelson M.R., Platts-Mills T.A.E., Wilson J.M. Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine. JAMA Netw. Open. 2021;4:e2124331. doi: 10.1001/jamanetworkopen.2021.24331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.24331</ArticleId><ArticleId IdType="pmc">PMC8414189</ArticleId><ArticleId IdType="pubmed">34473262</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Wang L.G., Han Y., He Q.Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287. doi: 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman A.M., Steen C.B., Liu C.L., Gentles A.J., Chaudhuri A.A., Scherer F., Khodadoust M.S., Esfahani M.S., Luca B.A., Steiner D., et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 2019;37:773–782. doi: 10.1038/s41587-019-0114-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0114-2</ArticleId><ArticleId IdType="pmc">PMC6610714</ArticleId><ArticleId IdType="pubmed">31061481</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>